Individualizing of Antihyperglycemic Agents in Type 2 Diabetes - Specialists


15 minutes



# of Credits



MOC - Section 1

Expiry Date


In this program we discuss the determination of how specific patient factors can help with the individualization of antihyperglycemic therapies

This event is an accredited group learning activity under Section 1 as defined by the Royal College of Physicians & Surgeons of Canada for the Maintenance of Certification program. It is approved by the Canadian Society of Endocrinology and Metabolism for a maximum of 0.25 credit(s).


David C.W. Lau (MD, PhD, FRCPC)
David Strain (MB, ChB, BSc (Hons) MD, FRCP)
Deanna Telner (MD, CCFP)
Elizabeth Rosolowsky (MD, MPH, FAAP, FRCPC)
Jeffrey Habert (MD, CCFP, FCFP)
John Axler (MD, CCFP, FCFP)
Peter J. Lin (MD, CCFP)
Robyn L. Houlden (MD, FRCPC)
Thomas Round (MBBS, BSc, DRCOG, MRCGP)

Upon completion of this program, participants will be able to:

1. Customize quickly and easily antihyperglycemic therapy for patients

Related Courses